Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |